Dispute Over Asthma Drug Puts Parents in Middle
Controversy surrounding Flovent, the most common asthma inhaler for children, reportedly has put parents in the middle of a fight between a drug company and pharmacy benefit managers.
Controversy surrounding Flovent, the most common asthma inhaler for children, reportedly has put parents in the middle of a fight between a drug company and pharmacy benefit managers.
What's Your Reaction?
